Release Tablets Advisory Committee Information Book Develco Pharma / PR Tablets Advisory Committee Information Book Develco Pharma / Advisory Committee ADR Adverse Drug Reaction AE / Advisory Committee Information Book Develco Pharma Schweiz AG / Information Book Develco Pharma AG / /
Single-Dose Administration / Mundipharma Drug Safety Department / UK MTD Maximum / World Health Organization / CSBM Complete / Federal Institute for Drugs and Medical Devices / Anesthetic and Analgesic Drug Products Advisory Committee / MHRA Medicines and Healthcare products Regulatory Agency / WHO Collaborating Centre for International Drug Monitoring / BSFS Bristol / FDA Division of Gastroenterology and Inborn Errors Products / Single-Dose Administration of Naloxone / DGIEP Division of Gastroenterology / SBM Spontaneous / US Federal Reserve / WHO World Health Organization / Analgesic Drug Products Advisory Committee / FDA / Inborn Errors Products / European Union / BM Bowel / s.c. Sub-cutaneous / /
Person
Hohenrainstrasse / / /
Position
General / AG / Executive / Major / /
Product
Talwin / reporting SMQ Standardized MedDRA query SOC System Organ Class SOWS Subjective Opioid / Withdrawal/ / Naloxone HCl / NLX PR Tablet / Nx / NALOXONE / Suboxone / opioid / PR Tablets / Prolonged Release Tablets / Pharmacokinetic Studies using NLX PR Tablets / NLX PR Tablets / Naloxone HCl Prolonged / PR / US / of / New Drug / Targinact® / /
Naloxone HCl PR Tablets Advisory Committee Information Book Develco Pharma Schweiz AG April 30, 2014